Market Research ReportDec 2, 2022

Immunoassays in R D Market

Immunoassays in R D Market Research Report: Size, Share, Trend Analysis Product & Services (Kits and Reagents, Analyzers, Software and Services), Type (ELISA, Enzyme-Linked Immunospot Assay (ELISpot), RadioImmunoassay (RIA), Chemiluminescence (CLIA), Fluoroimmnoassay, Others), Application (Infectious Diseases, Cancer Research, Endocrinology, Autoimmune Diseases, Application_Others), End User (Pharmaceutical and Biotechnology Companies, Academic Institutions and Laboratories, End User_Others) and By Region (Middle East and Africa, Americas, Asia Pacific, Europe) - Growth Outlook & Industry Forecast To 2023

Vertical: HealthcareBase Year: 201712 Sections

Book Demo

Executive Summary

Immunoassays in R D Market — Snapshot

Market Size (2017)
$4.75B
Projected (2023)
$7.72B
CAGR (2015–2023)
8.9%
Key Players
10+

The factors such as increasing demand for immunoassays in different sectors, and technological advancement for immunoassays in R&D are boosting the growth of the market. In addition, untapped emerging economies are propelling the growth of the market. The shortage of skilled professionals is providing significant growth opportunities for the market.

Key Insight

The Immunoassays in R D Market market is projected to grow at a CAGR of 8.9% from 2015 to 2023.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

Geographic Coverage: This analysis covers 4 regions: Middle East and Africa, Americas, Asia Pacific, Europe.
Market Segmentation: The market is analyzed across 3 segments: Kits and Reagents, Analyzers, Software and Services. Forecasts are provided for each segment from 2015 to 2023.
Competitive Landscape: 10 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Immunoassays in R D Market — Growth Trajectory

Immunoassays are a bioanalytical procedure, in which the quantitation of the analyte depends upon the reaction of an antigen (analyte) and an antibody. Immunoassays have been extensively used in many areas of pharmaceutical analysis such as diagnosis of diseases, therapeutic drug monitoring, and clinical pharmacokinetics and bioequivalence studies in drug discoveries.

Immunoassays in R D Market — Growth Trajectory

Kits and Reagents

Analyzers

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

Product & Services is analyzed as a distinct market dimension.
Type is analyzed as a distinct market dimension.
Application is analyzed as a distinct market dimension.
End User is analyzed as a distinct market dimension.

Geographic Analysis

Regional market breakdown

Middle East and Africa market size reached $306.50M in 2015 and is projected to reach $570.40M by 2023, growing at a CAGR of 8.1%.
Americas market size reached $1.50B in 2015 and is projected to reach $3.04B by 2023, growing at a CAGR of 9.2%.

Asia Pacific market size reached $835.40M in 2015 and is projected to reach $1.70B by 2023, growing at a CAGR of 9.3%.
Europe market size reached $1.25B in 2015 and is projected to reach $2.42B by 2023, growing at a CAGR of 8.5%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Immunoassays in R D Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

Base Year
2017
Historical Period
2015 – 2016
Forecast Period
2018 – 2023
Primary Interviews
150+

Research Process

Historical data (2015–2017) and forecast period (2017–2023)

Problem Definition

Market scoping
Objective setting
Framework design

Secondary Research

Literature review
Data mining
Trend analysis

Primary Research

Expert interviews
Field visits
Surveys

Data Analysis

Quantitative modeling
Statistical testing
Validation

Insights & Reporting

Synthesis
Recommendations
Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)

Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Immunoassays in R D Market — Competitive Analysis

Threat of New Entrants

The threat of new entrants in the global Immunoassays in R&D market is moderate. The global Immunoassays in R&D market is steadily growing, hence attracting many new entrants who are looking to make a profit. However, the entry barriers are high due to strict government norms and regulations which decreases the threat of new entrants to some level. Companies aim to increase their market share and capture the market share which is mostly untouched by major players. Hence, the threat of new entrants in the global Immunoassays in R&D market is expected to be moderate.

Bargaining Power of Suppliers

The bargaining power of suppliers in the global Immunoassays in R&D market is high as there is an increase in demand for raw materials by pharmaceutical companies. However, the number of suppliers is also high in the market, which is slightly decreasing the bargaining power of suppliers due to low switching costs. Additionally, the supply of raw materials is disrupted to some level due to the logistics issues that the world is facing currently, which in turn increases the bargaining power of suppliers.

Threat of Substitutes

The threat of substitutes in the Immunoassays in R&D market is low. Immunoassays as a whole do not have substitutes and are essential in diagnosis and R&D. They are essential in studying the binding between specific antigens and antibodies. However, there is an internal substitution in the market among products offered by different players. There are several players offering similar products at competitive prices, which increases the threat of substitutes between players.

Bargaining Power of Buyers

The bargaining power of buyers is moderate in the global Immunoassays in R&D market. There are a high number of players providing immunoassays at similar prices, however, test accuracy is key and only a few players provide high quality immunoassay products to be used in R&D. Hence, this lowers the bargaining power of buyers to some extent.

Intensity of Rivalry

The degree of competition in the Immunoassays in R&D market is high owing to the presence of a large number of prominent players. The low level of product differentiation among existing players increases the intensity of rivalry in the market. Key players are trying to develop economical and more accurate products to make their offerings more affordable and attractive. Such innovations might increase the level of product differentiation and will support the sales of the manufacturers.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Immunoassays in R D Market.

Regional Market Size (USD Mn)

Market estimates by geography (2023)

USD Mn

InsightAmericas leads with $3.04B by 2023, while Asia Pacific is projected to grow fastest at a 9.3% CAGR.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION	2015	2017	2023	CAGR	SHARE
Middle East and Africa	$306.50M	$447.60M	$570.40M	8.1%	7%
Americas	$1.50B	$2.22B	$3.04B	9.2%	39%
Asia Pacific	$835.40M	$1.17B	$1.70B	9.3%	22%
Europe	$1.25B	$1.85B	$2.42B	8.5%	31%
Total	$3.90B	$5.69B	$7.72B	8.9%	100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2023)

Kits and Reagents

Analyzers

Software and Services

01345

Kits and Reagents48%
Analyzers31%
Software and Services21%

Total Market Size

$7.72B

Market by Segment (2023)

APPLICATION	REVENUE ($B)	GROWTH RATE	MARKET PENETRATION
Kits and Reagents	$3.69B	9.3%	48%
Analyzers	$2.38B	8.4%	31%
Software and Services	$1.65B	8.8%	21%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Empower your Business
with Insights

Save over 20% on
Annual Subscription

Subscribe now

Book a demo

See plans for professionals or small and medium businesses.

Analytics

Immunoassays in R D Market — Key Findings

Analytical insights on Immunoassays in R D Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Immunoassays in R D Market market is projected to reach $7.72B by 2023, growing at 8.9% CAGR. The Kits and Reagents segment holds the largest share.

Market Dynamics

Increasing demand for immunoassays in different sectors and technological advancements are major factors driving the growth of the global immunoassays R&D market. However, the shortage of skilled professionals is expected to hamper the growth of the global market. Nevertheless, it is anticipated that the untapped emerging economies will create lucrative opportunities for the players operating in the global market.

Market Drivers

The demand for immunoassays in different sectors including the pharmaceutical & biopharmaceutical industries, contract research organizations, and academic institutes has rapidly increased in research and development processes which, in turn, has positively contributed to the market growth. Immunoassays have numerous applications in drug and vaccine development. The growing demand for small molecule drugs, innovative biologics, and regenerative pharmaceuticals & biopharmaceuticals drives up the demand for immunoassays in the pharmaceutical and biotechnology industries. Furthermore, ongoing trends such as increasing approvals of novel therapeutics and rising investments in cell & gene therapy is further bolstering the market growth.

Moreover, the demand for precision medicine is increasing owing to the rising prevalence of chronic diseases such as cancer, heart disease, and diabetes. As per the American Cancer Society, various types of cancer including colorectal cancer, breast cancer, lung cancer, certain types of leukemia, lymphoma, and melanoma has fuelled the demand for precision medicine. According to the World Cancer Research Fund International, colorectal cancer is the third most common cancer worldwide and accounted for 1.9 million new cases of colorectal cancer in 2020. It is the third most common cancer in men and the second most common cancer in women.

Hence, the growing demand for biologics, rapid approvals of novel therapeutics, increasing demand for precision medicine, and rising prevalence of cancer has boosted the adoption of immunoassays in R&D.

Market Opportunities

Emerging economies such as India, China, and France are experiencing lucrative growth opportunities due to the increasing population and the rising geriatric population. The huge population pool, a lack of awareness about health, the development of new diseases that require further research for drug development, and the rising incidences of chronic illnesses According to the Department of Economic and Social Affairs' World Population Prospects 2022, population growth by 2100 is expected to be 10.4 billion. The rising prevalence of communicable diseases such as COVID-19, dengue, hepatitis, measles, and the human immunodeficiency virus is propelling the adoption of immunoassays in R&D thereby aiding market growth.

As per the Joint United Nations Programme on HIV/AIDS (UNAIDS), there were 1.5 million newly infected people with HIV across the globe in 2021. Moreover, 38.4 million people were living with HIV in 2021. In addition, the high incidence of non-communicable diseases, including chronic lung disease, heart disease, stroke, cancer, and diabetes is positively contributing to the market growth. As per the World Health Organization, chronic obstructive pulmonary disease (COPD) was the third leading cause of death and accounted for 3.23 million deaths in 2019. As a result, rising population and communicable & noncommunicable disease incidences is driving the drug discovery and development and is anticipated to bolster the market growth in the coming years.

Market Restraints

The immunoassay market in R&D has been stifled due to a scarcity of skilled professionals. The rising requirement for drug discovery and development owing to increases in lifestyle changes and communicable and non-communicable diseases further requires advanced instruments to speed up the development of drugs and vaccines. Moreover, the pharmaceutical and biopharmaceutical industries are giving preference to intelligent automation, decentralization of clinical trials, and precision medicine, which further require a skilled workforce to run advanced technology.

The rising demand for advanced instruments further increases the demand for skilled professionals. Healthcare advancements coupled with high adoption of digital technologies have transformed the life sciences industries. Moreover, life science industries are currently competing with the IT and communications sectors for skilled engineers to work on new vaccines, precision medicine, and repurposed drugs. As a result, it is estimated that a talented workforce will be required during the forecast period in order to eliminate errors and provide high-quality results.

Strategic Outlook and Future Directions

The COVID-19 pandemic has significantly and positively impacted the global immunoassays in R&D market. During the pandemic immunoassays were extensively utilized to test for COVID-19. Immunoassays were used to detect the levels of antibodies for SARS-CoV-2 in human serum. Due to the pandemic, extensive R&D efforts were undertaken in order to develop accurate diagnostic products to test for COVID-19 which can be produced at mass, along with development of novel vaccines and drugs to counter the rising number of cases and effects of the virus. Additionally, immunoassays are employed in the production of vaccines to evaluate the titer, purity, affinity, potency, and immunogenic response of the vaccines in both animals and people. This had a positive impact on the market, significantly driving market growth.

The pandemic has impacted the business environment for several organizations worldwide. The supply chain in the global immunoassays in R&D market is the key to fulfilling customer demands. In addition, due to the pandemic, several countries have imposed import and export limitations. This has also affected the healthcare industry as many countries are dependent on other countries for raw material supply and technology transfer. However, regulatory bodies took significant initiatives to ensure efficient supply chain management during the pandemic. Additionally, for immunoassays targeted at COVID-19 testing, there was a shortage of the same as demand for such kits and reagents had skyrocketed, while the production rate and laboratory testing capacities could not cope-up. To overcome such challenges, key players also expanded their manufacturing capabilities to meet demand. For instance, in July 2020, Becton, Dickinson and Company (BC) (US) received USD 24 million investment by the US government to ramp up manufacturing for its BD Veritor SARS-CoV-2 immunoassay tests to cater to global demand. Such initiatives aided in strengthening the supply chain. Similarly, in November 2022, Bio-Techne Corporation (US) also announced its opening of a 52,000 square foot immunoassay manufacturing facility in the US. Hence, the pandemic had moderately impacted the global immunoassays in R&D market.

The COVID-19 pandemic had positively impacted on players operating in the market. This is especially due to the new wave of demand and interest that has come into immunoassays and its applications in COIVD-19 research & vaccines development, and its diagnosis. Players such as BD (US), Roche (Switzerland) and Abbott (US) reported significant increase in sales of its immunoassay products owing to the pandemic. However, as the effects of the pandemic started to diminish, number of cases decline, and majority of the populations got vaccinated and the positive effects on revenue was expected to dry-up and return to normalcy. Hence, the pandemic had a positive impact on the market players.

Market Value by Segment (2023)

Value (USD Mn)

Kits and Reagents

Analyzers

Software and Services

Companies

Key companies profiled in Immunoassays in R D Market

Profiles of 105 companies operating in the Immunoassays in R D Market market, including revenue, employee count, and market positioning where available.

Region

Industry

Founded Year

Showing 105 of 105 companies

Abcam plc

Healthcare

Company Headquarters: Cambridge, UK Founded: 1998 Workforce: ~1,750 Company Working: Abcam plc is a global life sciences company that discovers, develops, and distributes high-quality biological reagents and tools for research, drug discovery, and diagnostics. It works across the industry to help life scientists complete their projects more quickly. It collaborates with life science organizations to develop novel binders for drug discovery, in-vitro diagnostics, and therapeutics. It supplies over 110,000 products to two-thirds of the world's life scientists to research protein targets, including antibodies, proteins, lysates, biochemicals, kits, and assays. It has thirteen locations globally and operates in over 130 countries worldwide. It manufactures its products in specialized facilities and sources them from over four hundred partners worldwide.

Sysmex Corporation

Company Headquarters: Kobe, Japan Founded: 1968 Workforce: ~ 8,715 Company Working: Sysmex Corporation (Sysmex) develops, manufactures, sells, and exports/imports diagnostic instruments, reagents, and related software. The company provides products, services, and support to customers in more than 190 countries. Its key customers include national and other public hospitals, private hospitals, universities, research institutes, other medical institutions. Sysmex operates in the domain of healthcare testing, which involves examining blood, urine, and other samples. The company's business is in the domain of in vitro diagnostics (IVD), which is essential to the diagnosis and treatment of diseases. The company operates through various subsidiaries in different parts of the world, including the Americas, EMEA, and Asia-Pacific.

Company Headquarters: Washington, D.C., US Founded: 1969 Workforce: ~71,000 Company Working: Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services all over the world. The company has five business segments, namely, life sciences, diagnostics, dental, water quality, and product identification. Its life sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. It also offers dental implant systems, high-precision individualized prosthetics, and CAD/CAM systems under the brand name Nobel Biocare. The company operates through more than 20 subsidiaries in the global market.

Siemens Healthineers

Company Headquarters: Founded: 1998 Workforce: 377,000 Company Working: Siemens Healthcare Private Limited is the distinctly managed healthcare business of Siemens AG empowering healthcare providers globally to meet their current challenges and to outperform in their respective environments. Siemens is a leader in medical technology. It is continuously updating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging in laboratory diagnostics and molecular medicine. It is dynamically developing its digital health and enterprise services.

Thermo Fisher Scientific

Manufacturing & Construction

United States, North America

Novavax, I

Novavax, Inc.

Healthcare

Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa

Page 1 of 18

…

Go to page

Charts

4 interactive charts drawn from the Immunoassays in R D Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.

Pro

Healthcare & PharmaJul 31, 2026

Global Immunoassays in R D Market Switzerland, Germany, Denmark, Spain, France, United Kingdom, Italy, Norway, Sweden, Rest Of Europe, Eastern-Europe and Rest Of Western Europe Of Europe

Pro

Healthcare & PharmaJul 31, 2026

Global Immunoassays in R D Market Australia, China, India, Japan, South Korea and Rest Of Asia Pacific By Country

Pro

Healthcare & PharmaJul 31, 2026

Global Immunoassays in R D Market Middle-East and Africa Of Middle East And Africa

Pro

Healthcare & PharmaJul 31, 2026

Global Immunoassays in R D Market By Region

Browse All Charts

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Similar Reports

View all

HealthcareJul 31, 2026

Stoma Ostomy Care Market

HealthcareJul 31, 2026

Ready-to-eat Popcorn Market

HealthcareJul 31, 2026

Organoids and Spheroids Market

Powering the world's best teams.
From next-gen startups to established enterprises.

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Immunoassays in R D Market

Immunoassays in R D Market Research Report: Size, Share, Trend Analysis Product & Services (Kits and Reagents, Analyzers, Software and Services), Type (ELISA, Enzyme-Linked Immunospot Assay (ELISpot), RadioImmunoassay (RIA), Chemiluminescence (CLIA), Fluoroimmnoassay, Others), Application (Infectious Diseases, Cancer Research, Endocrinology, Autoimmune Diseases, Application_Others), End User (Pharmaceutical and Biotechnology Companies, Academic Institutions and Laboratories, End User_Others) and By Region (Middle East and Africa, Americas, Asia Pacific, Europe) - Growth Outlook & Industry Forecast To 2023

Starting from

$4,950

Immunoassays in R D Market

Key Insight

Market Performance Trend

Market Scope & Coverage

What this report covers

Immunoassays in R D Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Immunoassays in R D Market — Competitive Analysis

Regional Market Data

Segment Revenue (2023)

Segment Market Share

Market by Segment (2023)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Opportunities

Market Restraints

Strategic Outlook and Future Directions

Market Value by Segment (2023)

About the Author

Healthcare Research Team

Market Performance Trend

Immunoassays in R D Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Immunoassays in R D Market — Competitive Analysis

Regional Market Data

Segment Revenue (2023)

Segment Market Share

Market by Segment (2023)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Opportunities

Market Restraints

Strategic Outlook and Future Directions

Market Value by Segment (2023)

About the Author

Healthcare Research Team

Save over 20% on
Annual Subscription

Save over 20% on
Annual Subscription